4//SEC Filing
FURLONG AMY 4
Accession 0001217747-11-000005
CIK 0001026650other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:50 PM ET
Size
22.3 KB
Accession
0001217747-11-000005
Insider Transaction Report
Form 4
FURLONG AMY
Exec V.P., Cardiac Safety
Transactions
- Tax Payment
Common Stock, $.01 par value
2011-03-02$6.32/sh−1,213$7,666→ 13,167 total - Award
Option (Right to Buy)
2011-03-02$6.46/sh+33,010$213,245→ 33,010 totalExercise: $6.46Exp: 2018-03-02→ Common Stock, $.01 par value (33,010 underlying) - Award
Common Stock, $.01 par value
2011-03-02+15,789→ 28,956 total
Holdings
- 50,000
Option (Right to Buy)
Exercise: $4.60Exp: 2016-03-02→ Common Stock, $.01 par value (50,000 underlying) - 20,000
Option (Right to Buy)
Exercise: $7.41Exp: 2014-02-23→ Common Stock, $.01 par value (20,000 underlying) - 20,000
Option (Right to Buy)
Exercise: $15.46Exp: 2012-02-14→ Common Stock, $.01 par value (20,000 underlying) - 11,250
Option (Right to Buy)
Exercise: $6.29Exp: 2013-04-22→ Common Stock, $.01 par value (11,250 underlying) - 30,104
Option (Right to Buy)
Exercise: $6.05Exp: 2017-02-26→ Common Stock, $.01 par value (30,104 underlying) - 20,250
Option (Right to Buy)
Exercise: $22.09Exp: 2014-02-09→ Common Stock, $.01 par value (20,250 underlying) - 5,625
Option (Right to Buy)
Exercise: $3.01Exp: 2012-07-23→ Common Stock, $.01 par value (5,625 underlying) - 25,000
Option (Right to Buy)
Exercise: $12.00Exp: 2015-02-28→ Common Stock, $.01 par value (25,000 underlying) - 20,000
Option (Right to Buy)
Exercise: $14.70Exp: 2013-02-10→ Common Stock, $.01 par value (20,000 underlying) - 7,500
Option (Right to Buy)
Exercise: $12.00From: 2009-02-28Exp: 2015-02-28→ Common Stock, $.01 par value (7,500 underlying)
Footnotes (4)
- [F1]Represents a restricted stock grant that vests in four equal annual installments beginning one year after date of grant.
- [F2]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
- [F3]25% of the total options granted became exercisable one year after date of grant. The remaining 75% became exercisable in December 2005.
- [F4]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable six years prior to expiration.
Documents
Issuer
ERESEARCHTECHNOLOGY INC /DE/
CIK 0001026650
Entity typeother
Related Parties
1- filerCIK 0001279452
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:50 PM ET
- Size
- 22.3 KB